Dita Gratzinger

Publications

• Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity. Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D. Am J Surg Pathol. 2013; 37 (4): 617-23
• Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Lab Invest. 2012; 92 (9): 1330-41
• Histoplasmosis presenting with ulcers on the soft palate. Ozdalga E, Gratzinger D. J Gen Intern Med. 2012; 27 (9): 1219
• IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report. Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D. Ocul Immunol Inflamm. 2012; 20 (5): 375-7
• In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, Levy R. Blood. 2012; 119 (2): 355-63
• CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Luo RF, Zhao S, Tibshirani R, Myklebust JH, Sanyal M, Fernandez R, Gratzinger D, Marinelli RJ, Lu ZS, Wong A, Levy R, Levy S, Natkunam Y. Hum Pathol. 2010; 41 (2): 271-80
• Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). Gratzinger D, Advani R, Zhao S, Talreja N, Tibshirani RJ, Shyam R, Horning S, Sehn LH, Farinha P, Briones J, Lossos IS, Gascoyne RD, Natkunam Y. Br J Haematol. 2010; 148 (2): 235-44
• The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y. Am J Clin Pathol. 2009; 131 (2): 264-78
• VEGF-C: putting the 'lymph' back in lymphoma? Gratzinger D, Leuk Lymphoma. 2009; 50 (3): 311-2
• Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression. Gratzinger D, Salama ME, Poh CF, Rouse RV. J Oral Pathol Med. 2008; 37 (3): 177-84
• LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Levy R, Gascoyne RD, Lossos IS. J Clin Oncol. 2008; 26 (3): 447-54
• Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Lossos IS, Natkunam Y. Lab Invest. 2008; 88 (1): 38-47
• Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Gratzinger D, Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y. Am J Pathol. 2007; 170 (4): 1362-9
• Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations. Biswas P, Zhang J, Schoenfeld JD, Schoenfeld D, Gratzinger D, Canosa S, Madri JA. Biochem Biophys Res Commun. 2005; 329 (4): 1225-33
• Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, Madri JA. J Cell Biol. 2003; 160 (4): 605-15
• Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. Gratzinger D, Canosa S, Engelhardt B, Madri JA. FASEB J. 2003; 17 (11): 1458-69
• Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif. Gratzinger D, Barreuther M, Madri JA. Biochem Biophys Res Commun. 2003; 301 (1): 243-9
• Interpreting a medium-resolution model of tubulin: comparison of zinc-sheet and microtubule structure. Wolf SG, Nogales E, Kikkawa M, Gratzinger D, Hirokawa N, Downing KH. J Mol Biol. 1996; 262 (4): 485-501